Ambu AS (WBO:AMBU) Tariff Resilience Score: 6/10 (As of Jul. 04, 2026)


WBO:AMBU Ambu AS WBO:AMBU
63 GF Score
Price €8.90
GF Value €17.17
Valuation Significantly Undervalued
View Full Analysis

What is Ambu AS Tariff Resilience Score?

Ambu AS WBO:AMBU +0.28% 63 Tariff Resilience Score is 6 as of Jul. 04, 2026. GuruFocus rates WBO:AMBU with a GF Score™ of 63/100 and a GF Value™ of €17.17 (Significantly Undervalued). Among 837 Medical Devices & Instruments companies, Ambu AS ranks better than 91.04% on this metric.

Ambu AS has the Tariff Resilience Score of 6, which implies that the company might have Average Resilient.

Ambu AS has Medical device company with global sales. Some exposure to tariffs on medical equipment, but benefits from industry-specific exemptions and strong global demand.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Ambu AS might have Average Resilient.

Ambu AS  (WBO:AMBU) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Ambu AS Tariff Resilience Score Related Terms

WBO:AMBU vs ABT, SYK, MDT: Tariff Resilience Score Comparison

For the Medical Devices subindustry, Ambu AS's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ambu AS Tariff Resilience Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Ambu AS's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Ambu AS's Tariff Resilience Score falls into.


WBO:AMBU
63GF Score
Ambu AS WBO:AMBU
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 6 mean?
Ambu AS (WBO:AMBU) has a Tariff Resilience Score of 6 as of Jul. 04, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Ambu AS ranks #75 out of 837 companies in the Medical Devices & Instruments industry, placing it in the top 9%.
Is Ambu AS's Tariff Resilience Score too high?
Ambu AS's current Tariff Resilience Score is 6. Based on the distribution chart, Ambu AS ranks #75 out of 837 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Ambu AS has a GF Score™ of 63/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ambu AS's Tariff Resilience Score compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Ambu AS ranks #75 out of 837 companies for Tariff Resilience Score. This places Ambu AS in the top 9% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Medical Devices & Instruments company?
A good Tariff Resilience Score depends on the Medical Devices & Instruments industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. Ambu AS's current Tariff Resilience Score is 6. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ambu AS stock overvalued right now?
Based on GuruFocus' analysis, Ambu AS (WBO:AMBU) is currently considered Significantly Undervalued. The stock's GF Value™ is €17.17, compared to a current price of €8.90 — trading 48.2% below its estimated fair value. The current Tariff Resilience Score is 6. Ambu AS's overall GF Score™ is 63/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Ambu AS (WBO:AMBU), the current Tariff Resilience Score is 6 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ambu AS (WBO:AMBU) Overvalued in 2026?

Based on GuruFocus' analysis, Ambu AS stock appears to be undervalued. The current stock price of €8.90 is trading 48.2% below its estimated GF Value™ of €17.17. GuruFocus considers Ambu AS to be Significantly Undervalued.

Key valuation signals for WBO:AMBU:

  • Tariff Resilience Score: 6
  • GF Value™: €17.17 vs. price of €8.90 (48.2% below fair value)
  • GF Score™: 63/100

No single metric tells the full story. See the WBO:AMBU stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ambu AS Business Description

Address Baltorpbakken 13, Ballerup, DNK, DK-2750
Ambu AS provides medical technology solutions. The company's business consists of research and development of new solutions, which are then manufactured, marketed, and sold. It operates in two verticals: Endoscopy Solutions and Anesthesia & Patient Monitoring, with the majority of revenue being generated from the Endoscopy Solutions business. Geographical segments include North America, Europe, and the Rest of the World.
63GF Score

Get the complete analysis for WBO:AMBU

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€8.90
Price
€17.17
GF Value